Eli Lilly & Co. (LLY) Raises FY23 Revenue Guidance to $33.4B-$33.9B vs Prior Guidance of $31.2B-$31.7B
Tweet
Share
E-mail
Get Alerts LLY Hot Sheet
Price: $1,137.82 --0%
Revenue Growth %: +25.9%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +25.9%
Financial Fact:
Asset impairments, restructuring, and other special charges: 45.5M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Eli Lilly & Co. (LLY) Raises FY23 Revenue Guidance to $33.4B-$33.9B vs Prior Guidance of $31.2B-$31.7B
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CoreWeave Added Over $25B Net New Customer Commitments Early In 3Q
- Lennar Corp. (LEN) Misses Q3 EPS by 10c
- Lilly to present diabetes and obesity drug data at EASD 2026
Create E-mail Alert Related Categories
Corporate News, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
